These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35073430)

  • 1. Disease mechanisms in Sjögren's syndrome: What do we know?
    Jonsson R
    Scand J Immunol; 2022 Mar; 95(3):e13145. PubMed ID: 35073430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.
    Jonsson R; Bolstad AI; Brokstad KA; Brun JG
    Ann N Y Acad Sci; 2007 Jun; 1108():433-47. PubMed ID: 17894008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Proteomics of Saliva in Sjögren's Syndrome.
    Katsiougiannis S; Wong DT
    Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Primary Sjögren's Syndrome.
    Chen W; Cao H; Lin J; Olsen N; Zheng SG
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):219-23. PubMed ID: 26362815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel autoantibodies in Sjögren's syndrome: A comprehensive review.
    Martín-Nares E; Hernández-Molina G
    Autoimmun Rev; 2019 Feb; 18(2):192-198. PubMed ID: 30572138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
    Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
    Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
    Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferons in Sjögren's syndrome.
    Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L
    Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary and serum soluble interleukin-2 receptor in primary Sjögren's syndrome.
    Tishler M; Yaron I; Shirazi I; Levartovsky D; Yaron M
    Arch Oral Biol; 1999 Apr; 44(4):305-8. PubMed ID: 10348356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and diagnosis of Sjögren's syndrome].
    Witte T
    Z Rheumatol; 2010 Feb; 69(1):50-6. PubMed ID: 20012975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations in salivary immunoglobulins in Sjögren's syndrome (author's transl)].
    Ghozlan R; Amor B; Mach PS; Delbarre F
    Rev Stomatol Chir Maxillofac; 1978; 79(2):113-7. PubMed ID: 278133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
    Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren's syndrome.
    Rhodus NL
    Quintessence Int; 1999 Oct; 30(10):689-99. PubMed ID: 10765853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjogren's Disease.
    Weisman MH
    Rheum Dis Clin North Am; 2016 Aug; 42(3):xi-xii. PubMed ID: 27431354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.